🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: CS1002

Found 0 matching trials

LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue Sarcomas

PHASE2

This phase II trial studies how well autologous tumor infiltrating lymphocy...

Status

Active Not Recruiting

Location

M D Anderson Cancer Center

Start Date

2018-04-27

Trial ID

NCT03449108

Treatments Being Tested

Aldesleukin Autologous Tumor Infiltrating Lymphocytes LN-145 Autologous Tumor Infiltrating Lymphocytes LN-145-S1 Cyclophosphamide Fludarabine Ipilimumab Nivolumab Quality-of-Life Assessment Questionnaire Administration

Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies

PHASE1

This phase Ib trial studies the side effects and best dose of selinexor whe...

Status

Terminated

Location

MD Anderson in The Woodlands

Start Date

2015-06-26

Trial ID

NCT02419495

Treatments Being Tested

Capecitabine Carboplatin Cyclophosphamide Doxorubicin Eribulin Fluorouracil Ipilimumab Irinotecan Hydrochloride Leucovorin Calcium Nivolumab Olaparib Oxaliplatin Paclitaxel Pembrolizumab Pemetrexed Selinexor Topotecan

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

PHASE1

This phase Ib trial investigates the side effects of the combination of niv...

Status

Withdrawn

Location

Lucile Packard Children's Hospital Stanford University

Start Date

2021-05-11

Trial ID

NCT04500548

Treatments Being Tested

Biospecimen Collection Ipilimumab Nivolumab

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN

PHASE1

This phase I/II trial studies the side effects and best dose of copanlisib ...

Status

Active Not Recruiting

Location

Dana-Farber Cancer Institute

Start Date

2020-07-17

Trial ID

NCT04317105

Treatments Being Tested

Biopsy Procedure Biospecimen Collection Computed Tomography Copanlisib Hydrochloride Echocardiography Test Ipilimumab Nivolumab X-Ray Imaging

Testing the Combination of Copanlisib, Nivolumab and Ipilimumab in Patients With Advanced Cancer and Lymphoma

PHASE1

This phase Ib trial studies the side effects and best dose of copanlisib an...

Status

Active Not Recruiting

Location

National Cancer Institute Developmental Therapeutics Clinic

Start Date

2018-08-14

Trial ID

NCT03502733

Treatments Being Tested

Biopsy Procedure Biospecimen Collection Computed Tomography Copanlisib Echocardiography Test Ipilimumab Magnetic Resonance Imaging Nivolumab

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

PHASE2

This phase II trial studies nivolumab and ipilimumab in treating patients w...

Status

Active Not Recruiting

Location

University of Alabama at Birmingham Cancer Center

Start Date

2017-01-30

Trial ID

NCT02834013

Treatments Being Tested

Biospecimen Collection Computed Tomography Echocardiography Test Ipilimumab Magnetic Resonance Imaging Nivolumab

Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery

PHASE2

This randomized phase II trial studies how well ipilimumab with or without ...

Status

Completed

Location

University of Alabama at Birmingham Cancer Center

Start Date

2014-01-24

Trial ID

NCT01950390

Treatments Being Tested

Bevacizumab Ipilimumab

Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

PHASE1

This phase I trial studies the side effects and best dose of nivolumab when...

Status

Terminated

Location

UC San Diego Moores Cancer Center

Start Date

2015-10-21

Trial ID

NCT02408861

Treatments Being Tested

Biospecimen Collection Bone Marrow Biopsy Computed Tomography Ipilimumab Nivolumab Positron Emission Tomography

Testing the Addition of Radiation Therapy to the Usual Treatment (Immunotherapy With or Without Chemotherapy) for Advanced Stage Non-small Cell Lung Cancer Patients Who Are PD-L1 Negative

PHASE2

This phase II/III trial compares the addition of radiation therapy to the u...

Status

Active Not Recruiting

Location

Mayo Clinic Hospital in Arizona

Start Date

2022-10-07

Trial ID

NCT04929041

Treatments Being Tested

Biopsy Procedure Biospecimen Collection Computed Tomography Echocardiography Test Ipilimumab Magnetic Resonance Imaging Nivolumab Positron Emission Tomography Quality-of-Life Assessment Radiation Therapy

Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors

PHASE2

This phase II trial studies how well the combination of XL184 (cabozantinib...

Status

Active Not Recruiting

Location

University of Alabama at Birmingham Cancer Center

Start Date

2020-08-06

Trial ID

NCT04079712

Treatments Being Tested

Cabozantinib S-malate Ipilimumab Nivolumab

Previous Next